EvoCell was established as a spinout company in the Institute of Genetics at the University of Nottingham in 2006 EvoCell operates in partnership with the University, and has been funded by a private investment team Our goal is to commercialize the scientific breakthroughs that have come as a natural consequence of the application of a novel evolutionary theory to cellular reprogramming We are seeking new avenues to commercialize our platform technology which enables us to reprogram normal somatic cells to a pluripotent state